| 000 | 03497naa a22005057i 4500 | ||
|---|---|---|---|
| 001 | UMUN-OA-20261005-PH-011 | ||
| 003 | local | ||
| 005 | 20261005174912.0 | ||
| 006 | m o d | ||
| 007 | cr|||||||||||| | ||
| 008 | 261005s2023 xx o u000 0 eng d | ||
| 024 | 7 |
_a10.1097/hep.0000000000000004 _2doi |
|
| 035 | _a(local)EuropePMC:PMC10026948 | ||
| 040 |
_alocal _beng _clocal |
||
| 041 | 0 | _aeng | |
| 100 | 0 |
_aZobair M Younossi _eauthor. |
|
| 245 | 1 | 4 |
_aThe global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. / _cZobair M Younossi; Pegah Golabi; James M Paik [and others]. |
| 264 | 1 |
_a[Place of publication not identified] : _b[publisher not identified], _c2023. |
|
| 300 | _a1 online resource (1 article). | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 500 | _aPublication type: Review article. | ||
| 500 | _aLinked open-access copy: published version. | ||
| 506 | 0 |
_aOpen access; no subscription required for the linked open-access version. _fUnrestricted online access _2star |
|
| 520 | 3 | _aBackground and aims NAFLD is a leading cause of liver-related morbidity and mortality. We assessed the global and regional prevalence, incidence, and mortality of NAFLD using an in-depth meta-analytic approach. Approach and results PubMed and Ovid MEDLINE were searched for NAFLD population-based studies from 1990 to 2019 survey year (last published 2022) per Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). Meta-analysis was conducted using random-effects models. Bias risk assessment was per Joanna Briggs Institute. Of 2585 studies reviewed, 92 studies (N=9,361,716) met eligibility criteria. Across the study period (1990-2019), meta-analytic pooling of NAFLD prevalence estimates and ultrasound-defined NAFLD yielded an overall global prevalence of 30.05% (95% CI: 27.88%-32.32%) and 30.69% (28.4-33.09), respectively. Global NAFLD prevalence increased by +50.4% from 25.26% (21.59-29.33) in 1990-2006 to 38.00% (33.71-42.49) in 2016-2019 ( p Conclusions NAFLD global prevalence is 30% and increasing which requires urgent and comprehensive strategies to raise awareness and address all aspects of NAFLD on local, regional, and global levels. | |
| 540 |
_aCreative Commons Attribution-NonCommercial-NoDerivatives. See the linked licence for the applicable terms. _uhttps://creativecommons.org/licenses/by-nc-nd/4.0/ |
||
| 546 | _aIn English. | ||
| 588 | 0 | _aDescription generated from Europe PMC bibliographic metadata retrieved on 5 October 2026; full text linked from the source. | |
| 590 | _aCourse allocation: B. Sc. Public Health. | ||
| 653 | _aB. Sc. Public Health | ||
| 653 | _aUMUN open access collection | ||
| 653 | _aepidemiology | ||
| 655 | 4 | _aReview articles. | |
| 700 | 0 |
_aPegah Golabi _eauthor. |
|
| 700 | 0 |
_aJames M Paik _eauthor. |
|
| 700 | 0 |
_aJames M Paik _eauthor. |
|
| 700 | 0 |
_aAustin Henry _eauthor. |
|
| 700 | 0 |
_aCatherine Van Dongen _eauthor. |
|
| 700 | 0 |
_aLinda Henry _eauthor. |
|
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gVol. 77, no. 4, (2023), pages/article 1335-1347 _x0270-9139 |
|
| 856 | 4 | 0 |
_uhttps://europepmc.org/articles/PMC10026948 _yRead open-access publication _zOpen access. _70 |
| 884 |
_aCourse selection and automated MARC21 enrichment from Europe PMC metadata. _g20261005 _khttps://europepmc.org/articles/PMC10026948 _qlocal |
||
| 942 | _n0 | ||
| 999 |
_c1283 _d1283 |
||